Aim Immunotech INC Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
AMEX
Reporting persons Mitchell P. Kopin, Daniel B. Asher, and Intracoastal Capital LLC have disclosed a zero percent beneficial ownership stake in AIM ImmunoTech Inc. as of May 27, 2026.
AMEX
SCHEDULE 13G/A: Armistice Capital and Steven Boyd Disclose Reduced Passive Stake in AIM ImmunoTech Inc. to 4.99%
Armistice Capital, LLC and Steven Boyd have filed an amendment to their Schedule 13G, disclosing a 4.99% passive ownership stake in AIM ImmunoTech Inc. as of December 31, 2024.